All Time HighSun Pharma has hit an all time high of Rs 653.35 on NSE
52 Week HighSun Pharma has hit a 52wk high of Rs 653.25 on NSE
AnnouncementsSun Pharma announces USFDA approval for generic Temodar
|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Aug' 13||Jun' 13|
Sun Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 126,786.30 crore.The company has reported a consolidated sales of Rs 4,286.59 crore and a Net Profit of Rs 1 crore for the quarter ended Dec 2013.
The company management includes Israel Makov - Chairman, Dilip S Shanghvi - Managing Director, Sudhir V Valia - Whole Time Director, Sailesh T Desai - Whole Time Director, S Mohanchand Dadha - Director, Hasmukh S Shah - Director, Keki M Mistry - Director, Ashwin Dani - Director, Rekha Sethi - Addnl.Independent Director.
It is listed on the BSE with a BSE Code of 524715 and the NSE with an NSE Code of SUNPHARMA.
Its Registered office is at Sun Pharma Advanced Research Centre (SP Tandalja,,Akota Road Vadodra,Gujarat - 390020.